SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-000898
Filing Date
2023-05-12
Accepted
2023-05-12 17:26:58
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4682_10q.htm   iXBRL 10-Q 1204219
2 EXHIBIT 31.1 e4682_ex31-1.htm EX-31.1 8468
3 EXHIBIT 31.2 e4682_ex31-2.htm EX-31.2 8537
4 EXHIBIT 32.1 e4682_ex32-1.htm EX-32.1 4913
5 EXHIBIT 32.2 e4682_ex32-2.htm EX-32.2 4844
  Complete submission text file 0001731122-23-000898.txt   5460768

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enob-20230331.xsd EX-101.SCH 41881
7 XBRL CALCULATION FILE enob-20230331_cal.xml EX-101.CAL 45571
8 XBRL DEFINITION FILE enob-20230331_def.xml EX-101.DEF 162780
9 XBRL LABEL FILE enob-20230331_lab.xml EX-101.LAB 330434
10 XBRL PRESENTATION FILE enob-20230331_pre.xml EX-101.PRE 272286
53 EXTRACTED XBRL INSTANCE DOCUMENT e4682_10q_htm.xml XML 821035
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 23917186
SIC: 2834 Pharmaceutical Preparations